Injected trivalent inactivated influenza vaccines are most commonly used throughout the world. Influenza antigen preparation varies between manufacturers.
In 2024, and as of 31 of January, approximately 10 000 CHIKVD cases and no deaths have been reported worldwide. A total of eight countries reported CHIKVD cases from the America (6) and Asia (2).
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.